Market Research Report

Ocular Hypertension Global Clinical Trials Review, H1, 2013

cover Published by GlobalData
Published Product code 242620
Content info Pages: 105
Price

Introduction

Abstract

Ocular Hypertension Global Clinical Trials Review, H1, 2013

Summary

GlobalData's clinical trial report, "Ocular Hypertension Global Clinical Trials Review, H1, 2013" provides data on the Ocular Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ocular Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ocular Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

TOC

Table of Contents

Table of Contents 2

  • List of Tables 5
  • List of Figures 6
  • Introduction 7
  • Ocular Hypertension 7
  • Report Guidance 7
  • Clinical Trials by Region 8
  • Clinical Trials by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by BRIC Nations 16
  • Clinical Trials by G7 Nations 17
  • Clinical Trials in G7 Nations by Trial Status 18
  • Clinical Trials by E7 Nations 19
  • Clinical Trials in E7 Nations by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Unaccomplished Trials of Ocular Hypertension 24
  • Subjects Recruited Over a Period of Time 27
  • Prominent Sponsors 28
  • Top Companies Participating in Ocular Hypertension Therapeutics Clinical Trials 30
  • Prominent Drug Comparison 32
  • Clinical Trial Profiles 33
  • Clinical Trial Overview of Top Companies 33
  • Alcon Research Ltd. 33
  • Clinical Trial Overview of Alcon Research Ltd. 33
  • Allergan, Inc. 37
  • Clinical Trial Overview of Allergan, Inc. 37
  • Pfizer Inc. 41
  • Clinical Trial Overview of Pfizer Inc. 41
  • Novartis AG 44
  • Clinical Trial Overview of Novartis AG 44
  • Santen Pharmaceutical Co., Ltd. 46
  • Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 46
  • Alcon, Inc. 48
  • Clinical Trial Overview of Alcon, Inc. 48
  • QLT Inc. 50
  • Clinical Trial Overview of QLT Inc. 50
  • Merck & Co., Inc. 51
  • Clinical Trial Overview of Merck & Co., Inc. 51
  • Kowa Company, Ltd. 52
  • Clinical Trial Overview of Kowa Company, Ltd. 52
  • Aerie Pharmaceuticals, Inc. 53
  • Clinical Trial Overview of Aerie Pharmaceuticals, Inc. 53
  • Bausch & Lomb Incorporated 54
  • Clinical Trial Overview of Bausch & Lomb Incorporated 54
  • Sylentis 55
  • Clinical Trial Overview of Sylentis 55
  • VISTAKON Pharmaceuticals, LLC 56
  • Clinical Trial Overview of VISTAKON Pharmaceuticals, LLC 56
  • Pharmaceutical Research Network LLC 57
  • Clinical Trial Overview of Pharmaceutical Research Network LLC 57
  • Sun Pharma Advanced Research Company 58
  • Clinical Trial Overview of Sun Pharma Advanced Research Company 58
  • Laboratorios Sophia S.A. de C.V. 59
  • Clinical Trial Overview of Laboratorios Sophia S.A. de C.V. 59
  • Aurolab 60
  • Clinical Trial Overview of Aurolab 60
  • PH&T S.p.A. 61
  • Clinical Trial Overview of PH&T S.p.A. 61
  • Alfred E. Tiefenbacher (GmbH & Co. KG) 62
  • Clinical Trial Overview of Alfred E. Tiefenbacher (GmbH & Co. KG) 62
  • Altheos, Inc. 63
  • Clinical Trial Overview of Altheos, Inc. 63
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals 64
  • Medical University of Vienna 64
  • Clinical Trial Overview of Medical University of Vienna 64
  • Aristotle University Of Thessaloniki 65
  • Clinical Trial Overview of Aristotle University Of Thessaloniki 65
  • Meir Medical Center 66
  • Clinical Trial Overview of Meir Medical Center 66
  • Federal University of Sao Paulo 67
  • Clinical Trial Overview of Federal University of Sao Paulo 67
  • University of Sao Paulo 68
  • Clinical Trial Overview of University of Sao Paulo 68
  • University of Parma 69
  • Clinical Trial Overview of University of Parma 69
  • The University of Ryukyu 70
  • Clinical Trial Overview of The University of Ryukyu 70
  • Dresden University of Technology 71
  • Clinical Trial Overview of Dresden University of Technology 71
  • Catholic University of the Sacred Heart 72
  • Clinical Trial Overview of Catholic University of the Sacred Heart 72
  • University Hospital of Larissa 73
  • Clinical Trial Overview of University Hospital of Larissa 73
  • The University of Tokyo 74
  • Clinical Trial Overview of The University of Tokyo 74
  • University of Zurich 75
  • Clinical Trial Overview of University of Zurich 75
  • Western Galilee Hospital-Nahariya 76
  • Clinical Trial Overview of Western Galilee Hospital-Nahariya 76
  • University of Cologne 77
  • Clinical Trial Overview of University of Cologne 77
  • University of Kentucky 78
  • Clinical Trial Overview of University of Kentucky 78
  • Walter Reed Army Medical Center 79
  • Clinical Trial Overview of Walter Reed Army Medical Center 79
  • Weill Cornell Medical College 80
  • Clinical Trial Overview of Weill Cornell Medical College 80
  • Universitaire Ziekenhuizen Leuven 81
  • Clinical Trial Overview of Universitaire Ziekenhuizen Leuven 81
  • Chinese University of Hong Kong 82
  • Clinical Trial Overview of Chinese University of Hong Kong 82
  • University of Calgary 83
  • Clinical Trial Overview of University of Calgary 83
  • Five Key Clinical Profiles 84

Appendix 102

  • Abbreviations 102
  • Definitions 102
  • Research Methodology 103
  • Secondary Research 103
  • About GlobalData 104
  • Contact Us 104
  • Disclaimer 104
  • Source 105

List of Tables

List of Tables

  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
  • Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
  • Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
  • Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
  • Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
  • Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 15
  • Ocular Hypertension Therapeutics Clinical Trials, BRIC Countries, 2013* 16
  • Ocular Hypertension Therapeutics Clinical Trials, G7 Countries, 2013* 17
  • Ocular Hypertension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
  • Ocular Hypertension Therapeutics Clinical Trials, E7 Countries, 2013* 19
  • Ocular Hypertension Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
  • Ocular Hypertension Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
  • Ocular Hypertension Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
  • Ocular Hypertension Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Alcon Research Ltd., 2013* 33
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2013* 37
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 41
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 44
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2013* 46
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Alcon, Inc., 2013* 48
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2013* 50
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 51
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2013* 52
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aerie Pharmaceuticals, Inc., 2013* 53
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Bausch & Lomb Incorporated, 2013* 54
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Sylentis, 2013* 55
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by VISTAKON Pharmaceuticals, LLC, 2013* 56
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmaceutical Research Network LLC, 2013* 57
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharma Advanced Research Company, 2013* 58
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorios Sophia S.A. de C.V., 2013* 59
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aurolab, 2013* 60
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by PH&T S.p.A., 2013* 61
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfred E. Tiefenbacher (GmbH & Co. KG), 2013* 62
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Altheos, Inc., 2013* 63
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013* 64
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aristotle University Of Thessaloniki, 2013* 65
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Meir Medical Center, 2013* 66
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2013* 67
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2013* 68
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Parma, 2013* 69
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Ryukyu, 2013* 70
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2013* 71
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Catholic University of the Sacred Heart, 2013* 72
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Larissa, 2013* 73
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2013* 74
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2013* 75
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Western Galilee Hospital-Nahariya, 2013* 76
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2013* 77
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2013* 78
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Walter Reed Army Medical Center, 2013* 79
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2013* 80
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitaire Ziekenhuizen Leuven, 2013* 81
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2013* 82
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2013* 83

List of Figures

List of Figures

  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
  • Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
  • Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
  • Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
  • Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
  • Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 15
  • Ocular Hypertension Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
  • Ocular Hypertension Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
  • Ocular Hypertension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
  • Ocular Hypertension Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
  • Ocular Hypertension Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
  • GlobalData Methodology 103

Ocular Hypertension Global Clinical Trials Review, H1, 2013 published by GlobalData in February 25, 2013. This report consists of Pages: 105 and the price starts from US $ 2500.

The contents of this page may be different from the latest version. Please contact us for details.

Back to Top